Rutgers University Researchers Develop PCR-Based SARS-CoV-2 Assay to Detect All Known Variants
The test uses "sloppy molecular beacons" that melt off at different temperatures to determine the specific variant.
Theralink Partners With George Mason, Rutgers Cancer Institute on Breast Cancer Test
The test, developed at George Mason, measures HER2 activation in a breast cancer biopsy to help determine if a patient will respond to treatment.
Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker
Interpace said that the novel monoclonal antibody, Das-1, will provide additional data regarding pancreatic cancer risk to guide personalized patient management.
Saliva Samples Slow to Catch On for Large-Scale Coronavirus Testing
A number of diagnostic labs have considered saliva-based SARS-CoV-2 testing but decided against it, while other groups continue to pursue it.
At-Home Coronavirus Tests Get Nod From FDA But Agency Proceeding With Caution
The FDA has added an at-home self-collection template to its SARS-CoV-2 EUA guidance as more firms seek to develop sampling kits for use in homes.